Use of extrusion-spheronization to develop an improved oral dosage form of indomethacin
- 28 March 1997
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 148 (2) , 201-209
- https://doi.org/10.1016/s0378-5173(96)04846-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Use of canonical and other analyses for the optimization of an extrusion-spheronization process for indomethacinInternational Journal of Pharmaceutics, 1997
- Dissolution, Bioavailability and Ulcerogenic Studies on Solid Dispersions of Indomethacin in Water Soluble Cellulose PolymersDrug Development and Industrial Pharmacy, 1994
- In Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of SurfactantsPharmaceutical Research, 1989
- Mode of action of penetration enhancers in human skinJournal of Controlled Release, 1987
- Comparison of Gastrointestinal pH in Dogs and Humans: Implications on the Use of the Beagle Dog as a Model for Oral Absorption in HumansJournal of Pharmaceutical Sciences, 1986
- The effect of hydrophilic polymers and surface active agents on the solubility of indomethacinInternational Journal of Pharmaceutics, 1985
- Bioavailability of metronidazole from sugar-coated tablets in humans. II. Evaluation of beagle dogs as an animal modelInternational Journal of Pharmaceutics, 1985
- Physicochemical Properties of Indomethacin and Related Compounds Co-Spray Dried with PolyvinylpyrrolidoneDrug Development and Industrial Pharmacy, 1985
- Comparative multiple dose kinetics of two formulations of indomethacinEuropean Journal of Clinical Pharmacology, 1983
- Pharmacokinetics of indomethacinClinical Pharmacology & Therapeutics, 1975